FIELD: medicine.
SUBSTANCE: ultrasonic data are used to measure prostate volume. Thereafter patient's blood is examined for levels of total and free prostate-specific antigen (PSA). Additionally, the age is patient reported. It is followed by calculating a diagnostic coefficient (Cd) by formula: Cd=6.14-0,18(A)-3.19(Ltpsa)+7.66(Ltpsa)+140[(Ltpsa):(Lp)]+0.09(Lp) wherein A is the patient's age, completed years; (Ltpsa) is the level of total PSA, ng/ml; (Lspsa) is the level of free PSA, ng/ml; (Lp) is prostate volume, cm3. If Cd>0, benign prostate hyperplasia is diagnosed. The value Cd<0 enables diagnosing prostate cancer.
EFFECT: technique enables high-reliability differential diagnosis of benign prostate hyperplasia and prostate cancer.
2 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR PROSTATE CANCER | 2011 |
|
RU2464574C1 |
METHOD OF DIFFERENTIA DIAGNOSTICS OF PROSTATE GLAND CANCER | 2007 |
|
RU2361520C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF MALIGNANT PROSTATIC TUMORS | 2003 |
|
RU2256924C2 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PROSTATE CANCER | 2012 |
|
RU2521389C2 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PROSTATE CANCER | 2011 |
|
RU2469333C1 |
DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING PROSTATE CARCINOMA CASES | 2004 |
|
RU2259163C1 |
METHOD FOR PREDICTING PROSTATIC CANCER | 2003 |
|
RU2245549C1 |
MARKER OF PROSTATE GLAND CANCER | 2007 |
|
RU2360924C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR MORPHOLOGICAL FORMS OF PROSTATE CANCER | 2011 |
|
RU2455643C1 |
METHOD OF DIAGNOSING PROSTATE CANCER IN PATIENTS AFTER ADENOMECTOMY | 2023 |
|
RU2812386C1 |
Authors
Dates
2012-10-20—Published
2011-08-09—Filed